High concordance between nonalcoholic fatty liver disease and metabolic dysfunction associated steatotic liver disease in the TARGET-NASH real world cohort.
A Sidney BarrittFeng YuAndrea R MospanPhilip Noel NewsomeMichael RodenHeather Lynne MorrisStephen CaldwellBrent A Neuschwander-Tetrinull nullPublished in: The American journal of gastroenterology (2024)
The new MASLD nomenclature is highly concordant with the prior TARGET-NASH pragmatic definitions.
Keyphrases